Avicanna

Avicanna Employees

15 people indexed:

Aras Azadian

Chief Executive Officer

295w.g9jxy41@7pbu1xhx.uk3 Sign up to see email

77jh.gg7h70l@7keex5ty.172 Sign up to see email
Arash Moghani

Executive Vice President, Operations & Technology

f1q84.8t4z0q8@7qe97kl5.6wb Sign up to see email

u40e4.32fby0q@3y26xj26.tdx Sign up to see email
Brennan Kerr

Vice President, Commercialization

w8jx3lw.0yu5@u2ux0u1u.3dx Sign up to see email

pflyl3h.ywd4@dpd4h9td.txx Sign up to see email
Dr. Frantz Le Devedec

Executive Vice President, Research & Product Development

gp.593pjq.q9.5x7w073@729qxx5q.9y1 Sign up to see email

3q.2k1hj9.k3.y4ppj0x@hqhkgxyq.k9y Sign up to see email
Dr. Karolina Urban

Executive Vice President, Scientific and Medical Affairs

5z.7ey8yjwz.yp9wt@w724z1wy.j4t Sign up to see email

p2.pswf09y9.457p4@493zxq3f.383 Sign up to see email
Enric Pujol

Vice President, People

29x5y.hqh9s@7qh9q5t2.s0z Sign up to see email

54wsd.0d74s@sxz1hky6.ws7 Sign up to see email
Ingrid Diaz

Vice President, Assistant General Counsel & Corporate Compliance Officer

he3w7p.54bx@e46yhwse.xek Sign up to see email

psy6s3.w4sh@2lk0fp67.050 Sign up to see email
Ivana Marić

Executive Vice President, Marketing

b7kp9.42hjp@8u84djfu.j71 Sign up to see email

s5s4d.05jp8@b6x8139d.gpz Sign up to see email
Jens Kramer

Vice President, European Operations

067h.93lf2h@zf5tz933.ddu Sign up to see email

1z5y.zbw39g@wpp8t1uy.xgz Sign up to see email
Juan David Gonzalez

Vice President, Avicanna LATAM S.A.S.

3631.4w87f.3stwwhs1@2f5pxhby.kwp Sign up to see email

7xr7.rf33t.byqyr8p9@85h6870r.t40 Sign up to see email
Lucas Nosiglia, MFin

President, Avicanna LATAM

6637t.ddx4t9r6.20t8@9rjwybh5.r0d Sign up to see email

q0kkj.20b176d0.zxke@ppz9kt84.9te Sign up to see email
Phillip Cardella

Chief Financial Officer

w60u8tt.sf21qw16@1x5tyu25.9zk Sign up to see email

xw93xju.ty83ywks@qfqxb0tf.sz7 Sign up to see email
Roland Alvarez

Vice President, Technical Operations

056ph8.x4g8uy6@hkbu5gb3.s33 Sign up to see email

j318f4.kk8u7pq@729t69by.gwu Sign up to see email
Samantha Watt

Vice President, Canadian Operations

xz0lrppb.4de1@k3ll9yzb.0by Sign up to see email

l207509x.b8eq@ell17q06.lgj Sign up to see email
Stephen Kim

Chief Legal Officer & General Counsel – AVICANNA USA INC.

2425y72.7jx@ujr1ldb5.ljd Sign up to see email

r6bu45y.3zf@gl1f04q5.j6g Sign up to see email

Avicanna Company Information

Avicanna is an international biopharmaceutical company engaged in the development and commercialization of advanced cannabinoid-based products. Based in Toronto, Canada, the company operates through four main business pillars: Medical Cannabis Products, Medical Cannabis Care, Pharmaceutical Products, and Active Pharmaceutical Ingredients. Avicanna has successfully commercialized over thirty proprietary, evidence-based products, facilitated by a robust scientific platform that includes research and development (R&D) and clinical development. In 2023, Avicanna reported a revenue of $16.8 million, marking a 314% increase from the previous year. The company’s R&D efforts are also supported by its Toronto headquarters, which focus on developing innovative drug delivery systems such as sustained release tablets, transdermal patches, and nano-particle formulations. Avicanna holds four pending patents, has received seven Canadian Government Research Grants since 2020, and possesses four Health Canada cannabis R&D licenses. Additionally, its subsidiary, Aureus Santa Marta, ensures a low-cost and consistent cannabinoid supply through in-house cultivation and extraction, having exported active pharmaceutical ingredients to 17 international markets. Avicanna is listed on multiple stock exchanges, including TSX: AVCN, OTCQX: AVCNF, and FSE: 0NN.

Report inaccurate information